Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,285,913
-$1,861,231 QoQ
Shares Held
634,985
-0.3% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#54
of 1,032 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. GSK ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
This page
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in GSK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,285,913 | 634,985 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $35,147,144 | 636,839 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,465,313 | 662,017 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,834,781 | 691,260 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,370,419 | 660,688 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,656,284 | 300,885 | Shares | Sole | 2025-05-15 | |
| 2022-03-31 | $22,775,634 | 533,092 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,014,735 | 485,853 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $18,011,667 | 480,614 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,922,548 | 458,900 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,415,777 | 440,391 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,288,536 | 451,288 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $16,461,650 | 445,906 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $19,567,101 | 489,094 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $17,987,696 | 484,028 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||